Red-bellied black snake venom neurotoxic protein (Pseudexin) (Pseudexin)

Pseudechis porphyriacus venom neurotoxic proteins, primarily represented by the pseudexin complex, are potent toxins found in the venom of the Red-bellied Black Snake. These proteins are classified as phospholipase A2 (PLA2) enzymes that exert their effects presynaptically at the neuromuscular junction [PubMed: 7250150]. By hydrolyzing phospholipids in the neuronal membrane, they inhibit the release of acetylcholine, which can lead to muscle weakness and respiratory failure in severe cases [PubMed: 3125567]. While the Red-bellied Black Snake is frequently involved in human envenomation, the clinical presentation is often dominated by local effects, myotoxicity, and anticoagulant activity rather than profound neurotoxicity [PubMed: 20524936]. In therapeutic settings, these venom proteins are the primary targets for antivenom therapy, where specific antibodies bind and neutralize the toxins before they can cause systemic damage [PubMed: 15130614]. Research into these proteins also provides insights into the structural biology of PLA2 enzymes and their potential applications in developing novel pharmacological agents. The pseudexin complex itself consists of multiple subunits with varying degrees of toxicity and enzymatic activity, contributing to the overall potency of the venom. Effective management of envenomation requires rapid administration of antivenom to prevent the irreversible binding of these neurotoxins to their targets.

Other names

PseudexinPseudechis porphyriacus neurotoxinsRed-bellied black snake PLA2Pseudechis porphyriacus phospholipase A2

Antivenom antibodies bind to the venom proteins (toxins), forming inactive complexes that prevent the toxins from interacting with their biological targets, such as presynaptic membranes at the neuromuscular junction.